Pressreleases

Sort by:

Filter by:

25 Jun 2013
Glycotope Has Completed Randomization of Phase II Clinical Trial with Glycooptimized and Fully Human FSH-GEXTM for In Vitro Fertilization

By admin

Glycotope GmbH, a global leader in optimizing the glycosylation of biopharmaceuticals, announced today that the Company completed randomization of patients on June 13th, 2013 in the Phase II clinical trial of its glycooptimized and fully human therapeutic protein FSH-GEXTM (follicle-stimulating hormone) to treat women undergoing intra-cytoplasmic sperm injection (ICSI) therapy.
25 Jun 2013
Glycotope Reported Promising First-in-Man Data at ASCO 2013 for its Glycooptimized anti-EGFR Antibody CetuGEX™ to Treat Solid Tumors

By admin

Glycotope GmbH, a global leader in optimizing the sugar chains (glycosylation) of biopharmaceuticals, announced full details of first-in-man Phase I trial data for CetuGEX™, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) with optimized and fully human glycosylation for a greatly enhanced anti-tumor activity and reduced side-effects. The data was presented at ASCO 2013 in the Developmental Therapeutics and Immunotherapy Session.
24 Jun 2013
PHT Corporation Launches Interactive New Website to Promote eClinical Technology Innovation

By admin

The new website showcases information and resources to promote the business, science, and regulatory benefits of adopting PRO and eCOA technologies in clinical research programs that collect patient data.
24 Jun 2013
Local CROs Unite for International Clinical Trials

By admin

Global CROs are no longer the obvious choice for companies looking to run international clinical trials. The motion is towards locally based CROs that are connected internationally to drive down R&D costs and leverage local know-how and quality.
20 Jun 2013
Meet Biovian at the ESACT congress 2013, 23-26 June 2013 at Lille Grand Palais, Lille, France.

By admin

Biovian's Director of Business Development and Projects, Antti Nieminen and Project Manager Ulla Myllymaa will be available for in-depth discussions with your delegates at stand number F10.
18 Jun 2013
PHT Corporation LogPad App™ System Collects Clinical Research Data from Apple and Android Smartphones

By admin

PHT Corporation announced the general availability of the LogPad App™ System that collects compliant patient data using the latest Apple and Android smartphones including patient’s own devices. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies along with post market and observational research, to massive patient populations.
18 Jun 2013
New BD Biosciences Flow Cytometry Cell Analyser Enables Complex Multicolour Experiments in Disease Research

By admin

19th June 2013, BD Biosciences announces the launch of the BD LSRFortessa™ X-20 Cell Analyser, the latest in its line of high-performance research flow cytometers, with the most compact footprint in its class.
18 Jun 2013
SHL Group invests in new KraussMaffei molding machines for medical device production

By admin

As SHL Group expands to provide customers with readily available services and production capabilities, the company insists on investing in high quality molding machines like those from KraussMaffei. SHL has been manufacturing with KraussMaffei high precision molding machines for years to produce the company's medical device products (such as auto injectors and pen injectors), and have purchased 10 more CX series machines following the company's recent expansion.
18 Jun 2013
Advantages of Pulsed UV Light R&D systems from SteriBeam over SteriPulse RS 3000 XL by Xenon Corp

By admin

Major parameters of the SteriPulse RS 3000 XL by Xenon Corp. have been compared with parameters of the fully automatic two lamp system with an interactive LCD display XeMaticA-2LFA and with the basic one lamp semi-automatic XeMaticA-SA-1L.
14 Jun 2013
Woodley Equipment Exhibiting at DIA 2013 at the Boston, MA

By admin

Woodley Equipment Company Inc. is exhibiting at DIA 2013 - 49th Annual Meeting. Come and visit us at Booth 760 at the Boston Convention and Exhibitor Center from 24 to 26th June 2013.

Drug Discovery

Research & Development

Enthorin and Rumi sign agreement for FXS therapy

Astellas and AI Proteins sign miniprotein therapeutics deal

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

Formation Bio launches $600m drug development fund

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Packaging & Supply Chain

Packaging

Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG

Gerresheimer at CPHI Frankfurt 2025

Suppliers

No data found

Pressreleases

Glycotope Has Completed Randomization of Phase II Clinical Trial with Glycooptimized and Fully Human FSH-GEXTM for In Vitro Fertilization

Glycotope Reported Promising First-in-Man Data at ASCO 2013 for its Glycooptimized anti-EGFR Antibody CetuGEX™ to Treat Solid Tumors

PHT Corporation Launches Interactive New Website to Promote eClinical Technology Innovation

Local CROs Unite for International Clinical Trials

Meet Biovian at the ESACT congress 2013, 23-26 June 2013 at Lille Grand Palais, Lille, France.

PHT Corporation LogPad App™ System Collects Clinical Research Data from Apple and Android Smartphones

New BD Biosciences Flow Cytometry Cell Analyser Enables Complex Multicolour Experiments in Disease Research

SHL Group invests in new KraussMaffei molding machines for medical device production

Advantages of Pulsed UV Light R&D systems from SteriBeam over SteriPulse RS 3000 XL by Xenon Corp

Woodley Equipment Exhibiting at DIA 2013 at the Boston, MA

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found

Search